[{"address1": "321 Summer Street", "address2": "Suite 400", "city": "Boston", "state": "MA", "zip": "02210", "country": "United States", "phone": "857 330 4340", "website": "https://www.inozyme.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Inozyme Pharma, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for rare diseases that affect bone health and blood vessel function. The company's lead product candidate consists of INZ-701, a soluble, recombinant, genetically engineered, and ENPP1 fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, and calciphylaxis, as well as patients with end-stage kidney disease receiving hemodialysis. It also develops Next Gen ERT for the treatment of ossification of the posterior longitudinal ligament (OPLL); and Gene therapy, a disease of the PPi-Adenosine Pathway. The company has license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.", "fullTimeEmployees": 67, "companyOfficers": [{"maxAge": 1, "name": "Dr. Douglas A. Treco Ph.D.", "age": 66, "title": "CEO & Chairman", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 591875, "exercisedValue": 0, "unexercisedValue": 116098}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9618, "open": 0.9437, "dayLow": 0.9051, "dayHigh": 1.0061, "regularMarketPreviousClose": 0.9618, "regularMarketOpen": 0.9437, "regularMarketDayLow": 0.9051, "regularMarketDayHigh": 1.0061, "payoutRatio": 0.0, "beta": 1.388, "forwardPE": -0.56759256, "volume": 305187, "regularMarketVolume": 305187, "averageVolume": 593416, "averageVolume10days": 465850, "averageDailyVolume10Day": 465850, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 59068864, "fiftyTwoWeekLow": 0.721, "fiftyTwoWeekHigh": 6.24, "fiftyDayAverage": 1.08682, "twoHundredDayAverage": 3.330705, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -7145138, "profitMargins": 0.0, "floatShares": 35838322, "sharesOutstanding": 64240200, "sharesShort": 4206464, "sharesShortPriorMonth": 4385790, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0655, "heldPercentInsiders": 0.01228, "heldPercentInstitutions": 0.92617, "shortRatio": 8.11, "shortPercentOfFloat": 0.0708, "impliedSharesOutstanding": 67195504, "bookValue": 0.9, "priceToBook": 1.0216666, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -102024000, "trailingEps": -1.62, "forwardEps": -1.62, "enterpriseToEbitda": 0.069, "52WeekChange": -0.7904328, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 0.9195, "targetHighPrice": 23.0, "targetLowPrice": 7.0, "targetMeanPrice": 13.5, "targetMedianPrice": 13.5, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 113087000, "totalCashPerShare": 1.76, "ebitda": -103288000, "totalDebt": 46873000, "quickRatio": 3.35, "currentRatio": 3.56, "debtToEquity": 81.059, "returnOnAssets": -0.40131, "returnOnEquity": -1.02896, "freeCashflow": -55088500, "operatingCashflow": -91907000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "INZY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "averageDailyVolume3Month": 593416, "fiftyTwoWeekLowChange": 0.19849998, "fiftyTwoWeekLowChangePercent": 0.27531204, "fiftyTwoWeekRange": "0.721 - 6.24", "fiftyTwoWeekHighChange": -5.3205, "fiftyTwoWeekHighChangePercent": -0.85264426, "fiftyTwoWeekChangePercent": -79.04328, "earningsTimestamp": 1741609800, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.62, "epsForward": -1.62, "epsCurrentYear": -1.105, "priceEpsCurrentYear": -0.8321267, "fiftyDayAverageChange": -0.16732001, "fiftyDayAverageChangePercent": -0.15395375, "twoHundredDayAverageChange": -2.4112048, "twoHundredDayAverageChangePercent": -0.72393227, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-07-24", "averageAnalystRating": "1.4 - Strong Buy", "corporateActions": [], "postMarketTime": 1744934138, "regularMarketTime": 1744920001, "exchange": "NMS", "messageBoardId": "finmb_568596329", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.3980026, "regularMarketPrice": 0.9195, "marketState": "CLOSED", "cryptoTradeable": false, "firstTradeDateMilliseconds": 1595597400000, "postMarketChangePercent": 2.05546, "postMarketPrice": 0.9384, "postMarketChange": 0.0189, "regularMarketChange": -0.042299986, "regularMarketDayRange": "0.9051 - 1.0061", "fullExchangeName": "NasdaqGS", "shortName": "Inozyme Pharma, Inc.", "longName": "Inozyme Pharma, Inc.", "displayName": "Inozyme Pharma", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]